Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DarioHealth (DRIO) Net Income towards Common Stockholders (2016 - 2025)

DarioHealth filings provide 13 years of Net Income towards Common Stockholders readings, the most recent being $7.5 million for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders fell 40.23% to $7.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$48.2 million, a 82.11% decrease, with the full-year FY2025 number at -$44.0 million, down 170.99% from a year prior.
  • Net Income towards Common Stockholders hit $7.5 million in Q4 2025 for DarioHealth, up from -$18.9 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $12.5 million in Q4 2024 to a low of -$22.9 million in Q3 2021.
  • Median Net Income towards Common Stockholders over the past 5 years was -$14.8 million (2022), compared with a mean of -$12.4 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 280.91% in 2021 and later surged 158.99% in 2023.
  • DarioHealth's Net Income towards Common Stockholders stood at -$19.2 million in 2021, then rose by 28.92% to -$13.6 million in 2022, then surged by 158.99% to $8.0 million in 2023, then surged by 55.25% to $12.5 million in 2024, then plummeted by 40.23% to $7.5 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were $7.5 million (Q4 2025), -$18.9 million (Q3 2025), and -$22.8 million (Q2 2025) per Business Quant data.